Esaote Group's Groundbreaking Innovations at ECR 2026
The Esaote Group, renowned for its innovative healthcare solutions, is set to make waves at the
European Congress of Radiology 2026 in Vienna. Known for its expertise in medical imaging, the company will spotlight its latest innovations in ultrasound and magnetic resonance imaging (MRI) aimed at enhancing diagnostic precision and improving patient outcomes.
Key Ultrasound Innovations
During the congress, Esaote will officially launch its two groundbreaking ultrasound systems: the
MyLab™E85 GTS and the
MyLab™C30 GTS Edition. Slated for presentation on March 5, 2026, at 11:30 AM, these systems embody Esaote's commitment to advancing interventional radiology. Marta Daniel, the GTS Product and Clinical Solutions Manager at Esaote, emphasizes that these state-of-the-art ultrasound systems are designed to be the most reliable and intuitive tools for interventionists.
The
MyLab™E85 GTS features advanced imaging technologies aimed at providing precise diagnoses, featuring exceptional needle visualization alongside enhanced procedural guidance via the
Virtual Navigator and the exclusive
Ablation Confirmation Suite. By providing real-time multimodal imaging for accurate navigation, the MyLab™E85 enhances ultrasound as a dependable alternative to CT-guided interventions.
On the other hand, the
MyLab™C30 GTS ups the ante with its portability and outstanding imaging quality. This system is the first of its kind to incorporate contrast-enhanced, shear-wave elastography, and attenuation imaging modes in a compact unit designed for clinical settings, underscoring Esaote's flexibility to adapt to diverse medical environments.
Pioneering Developments in MRI
In terms of MRI, Esaote will showcase important innovations that reflect their vision of an intelligent and clinically-focused MRI solution. Highlighted at ECR 2026 are two vital components:
HyperSpeed, a revolutionary AI module that significantly accelerates MRI scanning times without compromising image quality, and
M-Score, a quantitative software tool that facilitates the assessment of bone health through opportunistic screening during routine lumbar MRI scans. These technologies are part of a workshop titled
“Beyond Images: Driving Clinical Value in MRI through AI technologies,” scheduled for March 6, 2026.
This workshop, led by Francesco Arrigoni and Federico Bruno from the University of L’Aquila, will delve into how AI can enhance clinical workflows and outcomes in imaging.
Advancements in Healthcare IT
The Esaote Group’s IT company, Ebit, will also present the latest iteration of
SUITESTENSA for radiology and enterprise imaging. This advanced AI-driven workflow orchestration integrates seamlessly into daily clinical operations, offering improved structured reporting and measurable efficiency gains for radiologists, all while ensuring clinical control and data governance remain intact.
Built on a cloud-native architecture, this platform embeds AI and quantitative tools directly into the reporting workflow, demonstrating Esaote's commitment to leveraging technology to elevate healthcare standards worldwide.
Company Profile
Esaote Group stands as a global leader in medical imaging, specializing in ultrasound, MRI, and management software for diagnostic processes. As of the end of 2025, the company boasts a workforce of approximately 1,300 employees, with half based in Italy. With production and research facilities located in Genoa and Florence and a presence in over 100 countries, Esaote continues to push the boundaries of medical imaging technology.
For more information about Esaote and its innovative products, visit their official website at
www.esaote.com.